SOURCE-LINKED INTELLIGENCE

GUIDE-AI – Guiding your treatment with current evidence

CORDIS · observation · Publication date unknown

patients with chronic illness. Yet, a large number of patients are not receiving all medications as recommended given the length and complexity of guidelines. The ambition of GUIDE-AI is to leverage generative AI to increase guideline adherence of chronically ill patients in Europe. GUIDE-AI will be developed as a blueprint on three indications: Chronic obstructive pulmonary disease, chronic heart failure, and chronic kidney disease. This setup can be expanded to other chronic diseases where clinical practice guidelines exist or be updated with the new guideline once published. GUIDE-AI has three objectives: OBJ-A[people-centricity]: GUIDE-AI integrates the perspectives of patients, physicians, healthcare administrators, and payers, addressing both inpatient and outpatient care and covering the full treatment continuum—from diagnosis and therapy initiation to long-term monitoring and treatment adjustments. OBJ-B [Innovate & Integrate]: GUIDE-AI computer scientists and clinicians will develop the technical set-up of the guideline navigators including benchmarking and red teaming on r

Read original source ↗ Open in workspace

recordType

award

status

SIGNED

region

EU

value

4895668

unit

EUR